An overview of hydrogen deuterium exchange mass spectrometry (HDX-MS) in drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 17, 2017 Category: Drugs & Pharmacology Authors: Glenn R. Masson Meredith L. Jenkins John E. Burke Source Type: research

Perspectives on optical biosensor utility in small-molecule screening
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 10, 2017 Category: Drugs & Pharmacology Authors: Tim Kaminski Stefan Geschwindner Source Type: research

New drug discovery approaches targeting recurrent mutations in chronic lymphocytic leukemia
Volume 12, Issue 10, October 2017, Page 1041-1052 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 4, 2017 Category: Drugs & Pharmacology Authors: Rupal Tripathi Eriong Lee-Verges Morihiro Higashi Neus Gimenez Laia Rosich Monica Lopez-Guerra Dolors Colomer Source Type: research

Computer-aided drug design: time to play with novel chemical matter
Volume 12, Issue 10, October 2017, Page 977-980 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 4, 2017 Category: Drugs & Pharmacology Authors: Xavier Barril Source Type: research

New drug discovery approaches targeting recurrent mutations in chronic lymphocytic leukemia
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 4, 2017 Category: Drugs & Pharmacology Authors: Rupal Tripathi Eriong Lee-Verges Morihiro Higashi Neus Gimenez Laia Rosich Monica Lopez-Guerra Dolors Colomer Source Type: research

Computer-aided drug design: time to play with novel chemical matter
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 4, 2017 Category: Drugs & Pharmacology Authors: Xavier Barril Source Type: research

Approaches for discovering novel bioactive small molecules targeting autophagy
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 31, 2017 Category: Drugs & Pharmacology Authors: Hui-yun Hwang Sung Min Cho Ho Jeong Kwon Source Type: research

Therapeutic targeting of leukemic stem cells in acute myeloid leukemia – the biological background for possible strategies
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 27, 2017 Category: Drugs & Pharmacology Authors: Øystein Bruserud Elise Aaseb ø Maria Hernandez-Valladares Galina Tsykunova H åkon Reikvam Source Type: research

Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 20, 2017 Category: Drugs & Pharmacology Authors: Georg Karpel-Massler Chiaki Tsuge Ishida Yiru Zhang Marc-Eric Halatsch M.-Andrew Westhoff Markus D. Siegelin Source Type: research

Organotypic cultures of cerebellar slices as a model to investigate demyelinating disorders
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 20, 2017 Category: Drugs & Pharmacology Authors: Fr édéric Doussau Jean-Luc Dupont Dorine Neel Aline Schneider Bernard Poulain Jean Louis Bossu Source Type: research

Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 20, 2017 Category: Drugs & Pharmacology Authors: Georg Karpel-Massler Chiaki Tsuge Ishida Yiru Zhang Marc-Eric Halatsch M.-Andrew Westhoff Markus D. Siegelin Source Type: research

Organotypic cultures of cerebellar slices as a model to investigate demyelinating disorders
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 20, 2017 Category: Drugs & Pharmacology Authors: Fr édéric Doussau Jean-Luc Dupont Dorine Neel Aline Schneider Bernard Poulain Jean Louis Bossu Source Type: research

The preclinical discovery and development of brexpiprazole for the treatment of major depressive disorder
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 18, 2017 Category: Drugs & Pharmacology Authors: Awais Aftab Keming Gao Source Type: research

Representation and identification of activity cliffs
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 13, 2017 Category: Drugs & Pharmacology Authors: J ürgen Bajorath Source Type: research

Novel approaches to the design of bioavailable melanotropins
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 12, 2017 Category: Drugs & Pharmacology Authors: Yang Zhou Minying Cai Source Type: research

Novel strategies for anti-aging drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 11, 2017 Category: Drugs & Pharmacology Authors: Komal Saraswat Syed Ibrahim Rizvi Source Type: research

Stabilization of protein-protein interactions in drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 11, 2017 Category: Drugs & Pharmacology Authors: Sebastian A. Andrei Eline Sijbesma Michael Hann Jeremy Davis Gavin O ’Mahony Matthew W. D. Perry Anna Karawajczyk Jan Eickhoff Luc Brunsveld Richard G. Doveston Lech-Gustav Milroy Christian Ottmann Source Type: research

Novel strategies for anti-aging drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 11, 2017 Category: Drugs & Pharmacology Authors: Komal Saraswat Syed Ibrahim Rizvi Source Type: research

Stabilization of protein-protein interactions in drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 11, 2017 Category: Drugs & Pharmacology Authors: Sebastian A. Andrei Eline Sijbesma Michael Hann Jeremy Davis Gavin O ’Mahony Matthew W. D. Perry Anna Karawajczyk Jan Eickhoff Luc Brunsveld Richard G. Doveston Lech-Gustav Milroy Christian Ottmann Source Type: research

Biophysics: for HTS hit validation, chemical lead optimization, and beyond
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 6, 2017 Category: Drugs & Pharmacology Authors: Christine C. Genick S. Kirk Wright Source Type: research

Using zebrafish as a model to study the role of epigenetics in hearing loss
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 6, 2017 Category: Drugs & Pharmacology Authors: Yingzi He Beier Bao Huawei Li Source Type: research

Biophysics: for HTS hit validation, chemical lead optimization, and beyond
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 6, 2017 Category: Drugs & Pharmacology Authors: Christine C. Genick S. Kirk Wright Source Type: research

Using zebrafish as a model to study the role of epigenetics in hearing loss
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 6, 2017 Category: Drugs & Pharmacology Authors: Yingzi He Beier Bao Huawei Li Source Type: research

The latest advances in the discovery of nitric oxide hybrid drug compounds
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 30, 2017 Category: Drugs & Pharmacology Authors: Ricardo A. M. Serafim Filipe G. Pernichelle Elizabeth I. Ferreira Source Type: research

Lipophilicity and biomimetic properties to support drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 28, 2017 Category: Drugs & Pharmacology Authors: Fotios Tsopelas Constantinos Giaginis Anna Tsantili-Kakoulidou Source Type: research

Erratum
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 26, 2017 Category: Drugs & Pharmacology Source Type: research

Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 26, 2017 Category: Drugs & Pharmacology Authors: Lucas Moreno Hubert Caron Birgit Geoerger Angelika Eggert Gudrun Schleiermacher Penelope Brock Dominique Valteau-Couanet Louis Chesler Johannes H Schulte Katleen De Preter Jan Molenaar Alexander Schramm Martin Eilers Tom Van Maerken John Inge Johnsen Mich Source Type: research

Erratum
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 26, 2017 Category: Drugs & Pharmacology Source Type: research

Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 26, 2017 Category: Drugs & Pharmacology Authors: Lucas Moreno Hubert Caron Birgit Geoerger Angelika Eggert Gudrun Schleiermacher Penelope Brock Dominique Valteau-Couanet Louis Chesler Johannes H Schulte Katleen De Preter Jan Molenaar Alexander Schramm Martin Eilers Tom Van Maerken John Inge Johnsen Mich Source Type: research

The discovery and development of romidepsin for the treatment of T-cell lymphoma
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 22, 2017 Category: Drugs & Pharmacology Authors: Piotr Smolewski Tadeusz Robak Source Type: research

Current mathematical models for cancer drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 22, 2017 Category: Drugs & Pharmacology Authors: Letizia Carrara Silvia Maria Lavezzi Elisa Borella Giuseppe De Nicolao Paolo Magni Italo Poggesi Source Type: research

The discovery and development of romidepsin for the treatment of T-cell lymphoma
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 22, 2017 Category: Drugs & Pharmacology Authors: Piotr Smolewski Tadeusz Robak Source Type: research

Current mathematical models for cancer drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 22, 2017 Category: Drugs & Pharmacology Authors: Letizia Carrara Silvia Maria Lavezzi Elisa Borella Giuseppe De Nicolao Paolo Magni Italo Poggesi Source Type: research

An omics perspective to the molecular mechanisms of anticancer metallo-drugs in the computational microscope era
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 21, 2017 Category: Drugs & Pharmacology Authors: Angelo Spinello Alessandra Magistrato Source Type: research

Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 12, 2017 Category: Drugs & Pharmacology Authors: Micha ł M. Nowotka Anna Gaulton David Mendez A. Patricia Bento Anne Hersey Andrew Leach Source Type: research

Future drug discovery in renin-angiotensin-aldosterone system intervention
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 9, 2017 Category: Drugs & Pharmacology Authors: Maria Tamargo Juan Tamargo Source Type: research

The advancement of multidimensional QSAR for novel drug discovery - where are we headed?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 8, 2017 Category: Drugs & Pharmacology Authors: Tao Wang Xin-song Yuan Mian-Bin Wu Jian-Ping Lin Li-Rong Yang Source Type: research